Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wolff

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
Oncology Research and Treatment|January 24, 2024
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of PhysiciansSascha Eickmann, Daniel Wolff, Guido Kobbe, et al.
Applied Microbiology and Biotechnology|January 16, 2013
Production of tetraacetyl phytosphingosine (TAPS) in Wickerhamomyces ciferrii is catalyzed by acetyltransferases Sli1p and Atf2pFrank Ter Veld, Daniel Wolff, Christoph Schorsch, et al.
BMC Palliative Care|February 11, 2025
" I can't do it anymore": a qualitative study on the emergence of crisis in outpatient palliative care-the perspective of family caregiversSofia Azhar, Anne Herrmann-Johns, Daniel Wolff, et al.
Frontiers in Oncology|May 12, 2020
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory TherapyAnna-Sophia Kattner, Ernst Holler, Wolfgang Herr, et al.
Bone Marrow Transplantation|October 24, 2018
Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinibMatthias A Fante, Ernst Holler, Barbara Schmidt, et al.
British Journal of Haematology|May 7, 2015
Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphomaPeter Ugocsai, Daniel Wolff, Karin Menhart, et al.
Oncology|June 23, 2017
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology PatientsMarina Hierl, Jochen Pfirstinger, Reinhard Andreesen, et al.
Access Microbiology|October 1, 2021
Human bocavirus 1 respiratory tract reactivations or reinfections in two adults, contributing to neurological deficits and deathRajita Rayamajhi Thapa, Annelie Plentz, Matthias Edinger, et al.
Annals of Hematology|August 4, 2019
Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experienceSebastian Klobuch, Daniela Weber, Barbara Holler, et al.
Frontiers in Immunology|May 17, 2021
Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host DiseaseAntonela Lelas, Hildegard Theresia Greinix, Daniel Wolff, et al.
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
Oncology Research and Treatment|January 24, 2024
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of PhysiciansSascha Eickmann, Daniel Wolff, Guido Kobbe, et al.
Applied Microbiology and Biotechnology|January 16, 2013
Production of tetraacetyl phytosphingosine (TAPS) in Wickerhamomyces ciferrii is catalyzed by acetyltransferases Sli1p and Atf2pFrank Ter Veld, Daniel Wolff, Christoph Schorsch, et al.
BMC Palliative Care|February 11, 2025
" I can't do it anymore": a qualitative study on the emergence of crisis in outpatient palliative care-the perspective of family caregiversSofia Azhar, Anne Herrmann-Johns, Daniel Wolff, et al.
Frontiers in Oncology|May 12, 2020
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory TherapyAnna-Sophia Kattner, Ernst Holler, Wolfgang Herr, et al.
Bone Marrow Transplantation|October 24, 2018
Persistent polyomavirus-associated nephropathy in a patient with GvHD and treatment with the JAK1/2 inhibitor ruxolitinibMatthias A Fante, Ernst Holler, Barbara Schmidt, et al.
British Journal of Haematology|May 7, 2015
Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphomaPeter Ugocsai, Daniel Wolff, Karin Menhart, et al.
Oncology|June 23, 2017
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology PatientsMarina Hierl, Jochen Pfirstinger, Reinhard Andreesen, et al.
Access Microbiology|October 1, 2021
Human bocavirus 1 respiratory tract reactivations or reinfections in two adults, contributing to neurological deficits and deathRajita Rayamajhi Thapa, Annelie Plentz, Matthias Edinger, et al.
Annals of Hematology|August 4, 2019
Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experienceSebastian Klobuch, Daniela Weber, Barbara Holler, et al.
Frontiers in Immunology|May 17, 2021
Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host DiseaseAntonela Lelas, Hildegard Theresia Greinix, Daniel Wolff, et al.
Pageof 21